CL

$CL

Colgate-Palmolive Company

Global consumer products company with oral care, personal care, and home care brands.

Consumer
$96.88
-1.97 (-1.99%)
Day Range$95.93 - $97.71
Prev Close$98.85

CL key facts as of November 14, 2026

Latest AI research report
CL Stock Analysis: Valuation, Dividend and Outlook (as of November 14, 2026)
StockAlpha report sentiment
Neutral (as of November 14, 2026)
Analyst consensus
Strong Buy (6 Strong Buy, 7 Buy, 7 Hold, 0 Sell, 1 Strong Sell) (as of November 1, 2026)
Analyst price target
$101.30 mean (range $95.00 to $112.00) (as of November 20, 2026)
Sector
Consumer
Analyst Rating
Strong Buy
13 Buy / 7 Hold / 1 Sell
Price Target
$101.30
4.6% upside
Subscribers
0
Tracking this ticker
Latest Report

Analysis from Nov 14, 2026

NEUTRAL

CL Stock Analysis: Valuation, Dividend and Outlook

Colgate-Palmolive’s defensive brands and cash generation support its steady profile, while a recent earnings beat adds a positive data point. At $99.67, however, the shares sit close to their 52-week high and the supplied analyst mean target, so valuation, margins and execution are key considerations.

Nov 14, 2026

CL FAQ

What is StockAlpha's latest view on CL?

StockAlpha's latest AI research report on Colgate-Palmolive Company (CL), "CL Stock Analysis: Valuation, Dividend and Outlook", was published on November 14, 2026 and rates the overall sentiment as neutral. Colgate-Palmolive’s defensive brands and cash generation support its steady profile, while a recent earnings beat adds a positive data point. At $99.67, however, the shares sit close to their 52-week high and the supplied analyst mean target, so valuation, margins and execution are key considerations.

When was the CL research last updated?

The most recent CL report was published on November 14, 2026.

What do analysts expect for CL?

As of November 1, 2026, the analyst consensus on CL is Strong Buy (6 Strong Buy, 7 Buy, 7 Hold, 0 Sell, 1 Strong Sell). As of November 20, 2026, the analyst price target is $101.30 mean (range $95.00 to $112.00).

Is this CL research investment advice?

No. StockAlpha.ai research is AI-generated analysis for informational purposes only and is not investment advice. Analyst figures are third-party data. Do your own research before making investment decisions.

Keep exploring